NCT04502732View on ClinicalTrials.gov

Gastric Emptying Using Two Imaging Methods for Those Who Have Undergone POSE2 Weight Loss Procedure

TerminatedOBSERVATIONAL
Enrollment

5

Participants

Timeline

Start Date

July 16, 2020

Primary Completion Date

November 23, 2020

Study Completion Date

November 23, 2020

Conditions
Weight Loss
Interventions
OTHER

NSSM and GEBT

The time to half gastric emptying (T1/2) will be assessed via Gastric Emptying Breath Tests (GEBT) and Nuclear Scintigraphy of a Solid Meal (NSSM) at baseline, 2 months, and 6 months. This data will be collected from seven adult subjects, with obesity, who have recently received Endoscopic Bariatric and Metabolic Therapy.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04502732 - Gastric Emptying Using Two Imaging Methods for Those Who Have Undergone POSE2 Weight Loss Procedure | Biotech Hunter | Biotech Hunter